The documented regulatory footprint for Skycade Med Corporation consists of one 510(k) premarket notification, K260168, recorded in the FDA 510(k) database. The record lists the applicant as Skycade Med Corporation of Dallas, Texas, with a Traditional clearance type, a Summary statement, and no third-party review. The device is described as Small Diameter Core Wire under two model designations, CMAN-000-00 and CMAN-000-14. The submission was received on 20 January 2026 and decided on 16 October 2026 as Substantially Equivalent. [1][5][7]
The cleared device and its regulatory classification
K260168 covers Small Diameter Core Wire in two configurations, CMAN-000-00 and CMAN-000-14. FDA classifies the device under product code DQX, regulation 870.1330, with the classification name Wire, Guide, Catheter, device class 2, and the cardiovascular advisory committee. The clearance type is Traditional, the statement or summary field reads Summary, and the third-party review flag is N. The decision code is SESE, described as Substantially Equivalent. [1][5][7]
The openFDA record carries the same identifiers and adds the applicant's filing address, 10048 Monroe Dr., Dallas, TX 75299, along with a contact name and the country code US. The Innolitics record reproduces the record ID, device name, applicant, product code and cardiovascular specialty. None of these records state an intended use, predicate device, bench testing, or labeling content for the core wire. [1][5]
Submission timeline
The filing dates are consistent across the FDA database entry, the FDA.report record and the Innolitics record: date received 20 January 2026, decision date 16 October 2026. The FDA 510(k) final-decisions listing for 16 October 2026 includes K260168 with a Substantially Equivalent decision and names Skycade Med Corporation as applicant for the Small Diameter Core Wire models. [1][3][7]
The same 16 October 2026 listing carries other applicants' clearances, including K262443 for Sofradim Production and K263234 for a miniature robotic system, which places K260168 among a broader set of decisions published that day rather than in isolation. [3]
What the public record does and does not establish
An independent company page states that, as of 17 November 2026, FDA public records list Skycade Med with one 510(k) clearance, the most recent dated 16 October 2026 for the Small Diameter Core Wire models. That count reflects the filings indexed at that date and is not a measure of sales, total portfolio or safety performance. [8]
A trade news item repeats the openFDA-derived details: Substantially Equivalent on 16 October 2026, Traditional 510(k) K260168, product code DQX, cardiovascular panel. No source in this set documents a parent company, brand ownership, manufacturing sites, customers, or commercial availability of the core wire, and the FDA filing address is not evidence of a headquarters location. [9]
Adjacent product-code context
Other clearances under product code DQX appear in third-party indexing, including K253146 for a Hyperdrive 35 Guidewire held by Rapid-Medical, Ltd. and K251181 for Splashwire Hydrophilic Guide Wire models held by Merit Medical Ireland, Ltd. These are separate applicants' records and do not describe Skycade Med's device or its regulatory basis. [7]

